Oncology

Synthetic data, tariffs, climate change… Ipsos Update explores the latest research and thinking on key topics from Ipsos teams around the world.

The cancer treatment landscape continues to evolve at speed. For all those working in oncology today, being able to adeptly respond to these shifts is imperative for brand success.

Read our new viewpoint and delve into the paradox of early cancer detection: how expanding screening methods – particularly multi-cancer early detection tests – while life-saving, pose considerations such as psychological impacts, false positives, and ethical dilemmas.

What are the promises and limitations of different therapeutic modalities in solid tumors? As we approach the mid-year point, we reflect on the advancements in oncology in recent years.

Capturing real-world anti-cancer drug treatment since 1991

Ipsos’ #1 therapy area of focus

Data, analysis, insights & predictions in our clients’ therapy areas of focus

This is the third and final paper in a series which began eight years ago, focusing on unravelling – and ultimately overcoming – the sheer complexity of cancer, one of humanity’s oldest and most formidable foes.

The oncology treatment landscape rarely stands still, and its constant evolution affects all those involved – from patients and their carers to cancer treaters to the companies who manufacture and market treatments.